Webinar: Patient Assistance in the Wake of COVID19

By Lash Group

As the U.S. economy continues to feel the ripple effect of the coronavirus pandemic and more Americans lose their jobs, will patients be able to afford their medications?

It’s a question that matters across therapeutic areas and one that will impact manufacturers’ commercialization strategies, especially as it relates to patient and provider support. 

Watch a panel of experts from Lash Group and Xcenda as they offer insights on:

  • How the COVID-19 pandemic will impact insurance coverage
  • The resulting affordability challenges patients will face
  • How manufacturers can adapt their patient assistance programs to ensure access to important therapies

Lash Group Experts

Mark Beightol lash group
Mark Beightol
Vice President, Client Delivery
Nicole Dunn
Vice President, Client Delivery
Fort Mill, SC
rose herring lash group
Rose Herring
Senior Director, Marketing
jack mcguire lash group
Jack McGuire, Pharm.D.
Vice President, Pharmacy Services

Xcenda Experts

Corey Ford
Corey Ford, MHA
Director, Reimbursement & Policy Insights
Xcenda
Melissa Mulchahey
Vice President, Field Services Client Engagement and Business Development
Xcenda